The GEN 7 Combat Application Tourniquet (C-A-T®) is the ultimate tool for controlling life-threatening extremity hemorrhage. Trusted by military, law enforcement, and emergency medical professionals worldwide, this CAT tourniquet is engineered for rapid, single-handed application, making it indispensable in critical situations.

The CAT Tourniquet Gen 7 features a patented free-moving internal band that provides true circumferential pressure to the limb, ensuring effective occlusion of blood flow. Its innovative windlass system, robust clip, and conical handle enhance reliability and ease of use, even under stress. Designed for durability, this combat application tourniquet Gen 7 is made from high-strength materials, capable of performing in extreme conditions.

Whether you're building a comprehensive first aid kit, upgrading your tactical gear, or ensuring preparedness for unexpected emergencies, the CAT Gen 7 Tourniquet is a non-negotiable component. It's an essential item for anyone involved in outdoor activities, tactical operations, or simply prioritizing personal and family safety. Don't compromise on bleeding control – choose the proven effectiveness of the tourniquet CAT.

Key Features & Benefits:

• Official GEN 7 C-A-T® Tourniquet: The latest generation for superior performance.
• Rapid Application: Designed for quick and effective one-handed self-application.
• True Circumferential Pressure: Patented internal band ensures effective blood flow occlusion.
• Enhanced Windlass System: Durable rod and clip provide secure locking mechanism.
• Conical Handle: Improved grip for easier and more efficient tightening.
• Lightweight & Compact: Easily fits into any first aid kit, trauma pouch, or tactical vest.
• Versatile Use: Ideal for military, police, EMS, adventurers, and home emergency preparedness.

Ensure you have the most reliable bleeding control device on hand. The GEN 7 Combat Application Tourniquet is a critical component for saving lives.

Brief History of the GEN 7 Combat Application Tourniquet (C-A-T®)

The Combat Application Tourniquet was initially fielded by USSOCOM in 2004 then fast followed by conventional forces in 2005. In the early years of the Global War on Terrorism (GWOT) and prior to the implementation of modern prefabricated tourniquets, the death rate from extremity exsanguination was 23.3 deaths annually. After full implementation, this number was reduced to 3.5 deaths per year, an 85% decrease in mortality. In 2005 the Combat Application Tourniquet was selected as one of the Army’s top 10 greatest inventions and is recognized as one of the foremost advancements in pre-hospital care during the GWOT with an estimated 1,850 lives saved.

Relentless comprehensive analysis of all deaths from extremity hemorrhage has resulted in evidence-based tourniquet improvements. This approach has yielded critical device improvements to include five refinements in the design of the Combat Application Tourniquet over the last decade. These enhancements were focused on maximizing the effectiveness of the device while minimizing morbidity.

Continuous interface with end-users and researchers, literature review and tourniquet applications in both real world and simulated high stress tactical environments have made it clear, that despite tremendous success, tourniquet knowledge gaps exist in the following areas (1) single verses double routing of the band (2) Importance of slack removal prior to engaging the windlass. Closing these gaps will be accomplished through device enhancements, knowledge products and focused training.